v3.26.1
Business Combinations (Details Narrative) - USD ($)
May 28, 2025
Oct. 11, 2024
Dec. 31, 2025
Jun. 02, 2025
Jun. 01, 2025
Dec. 31, 2024
Business Combination [Line Items]            
Common stock, par value     $ 0.0001     $ 0.0001
Common stock shares     477,366     3,111
NAYA Therapeutics Inc [Member]            
Business Combination [Line Items]            
Common stock shares $ 4,803,175          
Five Narrow Lane LP [Member]            
Business Combination [Line Items]            
Convertible debt   $ 8,575,833        
Convertible notes payable   $ 3,934,146        
Interest rate   7.00%        
Principal balance   $ 3,934,146        
Debt instrument maturity date   Dec. 11, 2025        
Five Narrow Lane LP [Member] | Common Stock [Member]            
Business Combination [Line Items]            
Converted shares to receive   465        
Series C-2 Convertible Preferred Stock [Member] | Five Narrow Lane LP [Member]            
Business Combination [Line Items]            
Converted shares to receive   8,576        
Conversion of stock description   The Company and FNL have agreed that the Company shall issue to FNL a pre-funded common stock purchase warrant (the “NAYA Acquisition Pre-funded Warrants”) to purchase up to 320 shares of the Company’s common stock in lieu of 320 shares of the aforementioned common stock. See Note 13 – Stockholders’ Equity for additional information on the Series C-2 Preferred.        
Legacy Naya Merger [Member] | Common Class A [Member]            
Business Combination [Line Items]            
Common stock, par value   $ 0.000001        
Legacy Naya Merger [Member] | Common Class B [Member]            
Business Combination [Line Items]            
Common stock, par value   $ 0.000001        
Legacy Naya Merger [Member] | Common Stock [Member]            
Business Combination [Line Items]            
Converted shares to receive   82        
Legacy Naya Merger [Member] | Series C-1 Convertible Preferred Stock [Member]            
Business Combination [Line Items]            
Converted shares to receive   30,375        
NAYA Therapeutics Inc [Member]            
Business Combination [Line Items]            
Redemption price $ 113.8558     $ 113.8558    
Common stock shares         3,227,813  
Preferred stock shares         6,300  
Interest rate 7.00%